HB
Hanall Biopharma
🇰🇷XKRX.009420South KoreaHealthcare
â‚©47,750.00KRWdown -850.00 (-1.75%)ClosedEnd of day5:15 PM
Priceâ‚©47,750.00-850.00 (-1.75%)
Profile
- Healthcare
- Drug Manufacturers - Specialty & Generic
- South Korea
Identity
- Exchange
- Korea Exchange . XKRX
- Type
- Stock
- ISIN
- KR7009420001
- CUSIP
- Not reported
Company
- Employees
- 304
- Headquarters
- Daejeon, South Korea
- Website
- https://www.hanall.co.kr
Market
- Shares outstanding
- 50.8M
- Market cap
- â‚©2.42T
Highlights
- Market cap
- â‚©2.47T
- EPS LTM
- â‚©44.00calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- Not reported
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- â‚©150.09B+15.12%up year on year
- Net income
- â‚©2.23B+136.07%up year on year
- Gross margin
- 53.27%+4.06%up year on year
- Free cash flow
- -â‚©5.46B-174.05%down year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.